Status:

COMPLETED

Tenofovir in HIV/HBV Coinfection

Lead Sponsor:

Kirby Institute

Collaborating Sponsors:

The University of New South Wales

Gilead Sciences

Conditions:

HIV Infection

Hepatitis B Coinfection

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

The purpose of the study is to compare the effectiveness of 3 different treatment regimens in reducing or clearing the Hepatitis B Virus in patients infected with HIV and Hepatitis B (co-infection)

Detailed Description

A randomised multi-centre trial of tenofovir vs lamivudine vs tenofovir/lamivudine in antiretroviral naïve subjects with HIV/HBV co-infection over 48 weeks (Clinical Trial A). Plus, a 12 week viral ki...

Eligibility Criteria

Inclusion

  • Written informed consent
  • Documented HIV infection (positive serology for HIV-1 and detectable HIV-1 RNA)
  • Age 18 - 70 years
  • HBV DNA \> 105 copies/ml
  • HBsAg positive \>6 months or HBsAg positive and anti HB core IgM negative
  • Creatinine \<= 2.0mg/dl (\<= 0.2 mmol/L)
  • Platelet count \>= 50,000/mm
  • HIV-1 antiretroviral therapy naïve
  • No prior exposure to anti-HBV agents (LAM, adefovir, TDF) although prior IFN treatment allowed

Exclusion

  • HCV-RNA positive or Anti-HAV IgM positive
  • Acute hepatitis (serum ALT \> 1000 U/L)
  • Active opportunistic infection
  • Other causes of chronic liver disease identified (autoimmune hepatitis, hemochromatosis, Wilsons disease, alfa-1-antitrypsin deficiency)
  • Concurrent malignancy requiring cytotoxic chemotherapy
  • Decompensated or Child's C cirrhosis
  • Alfa-fetoprotein (AFP) \> 3X ULN (unless negative CT scan or MRI within 3 months of entry date)
  • Pregnancy or lactation
  • Any other condition which in the opinion of the investigator might interfere with compliance or outcome of the study

Key Trial Info

Start Date :

January 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2007

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT00192595

Start Date

January 1 2004

End Date

January 1 2007

Last Update

April 1 2015

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

St. Vincent's Hospital

Darlinghurst, New South Wales, Australia, 2010

2

The Alfred Hospital

Melbourne, Victoria, Australia, 3004

3

Thai Red Cross AIDS Research Centre

Bangkok, Thailand